United Therapeutics (UTHR) Tops Q3 EPS by 23c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $514.89 +1.26%
Financial Fact:
Diluted (in shares): 46.2M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Diluted (in shares): 46.2M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $5.38, $0.23 better than the analyst estimate of $5.15. Revenue for the quarter came in at $609.4 million versus the consensus estimate of $587.9 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
